HeartFlow focuses on precision heart care, combining human ingenuity with technology. HeartFlow’s non-invasive HeartFlow FFRCT Analysis leverages artificial intelligence to create a personalized three-dimensional model of the heart. Clinicians can use this model to evaluate the impact a blockage has on blood flow and determine the best treatment for patients. HeartFlow’s technology is reflective of our Silicon Valley roots and incorporates over two decades of scientific evidence with the latest advances in artificial intelligence. The HeartFlow FFRCT Analysis is commercially available in the United States, UK, Canada, Europe, and Japan.

Part of Johnson & Johnson, DePuy International Ltd. is a company headquartered in Beeston, UK, that engages in manufacture of medical and dental instruments and supplies.

Imorphics Ltd. provides 3D medical image analysis software solutions. Its expertise include surgery, population study and clinical trials. The company was founded by Graham R. Vincent in 2002 and is headquartered in Manchester, the United Kingdom.

Boston Scientific Neuromodulation Corp. offers implantable pain management devices for neuromodulation. The company is headquartered in Marlborough, MA.

Manufactures healthcare equipment

BIOMODEX is an innovative medical technology company based in Paris and Boston using 3D printing to create tissue-like anatomical twins from medical images, for patient-specific rehearsal and advanced training. The anatomically accurate twin is designed to provide critical tactile feedback to users which, when paired with our simulated blood flow stations, offers a unique and tailored end to end physician experience.

Part of Surgical Science Sweden AB, Simbionix Ltd. is an Israeli company located in Airport City. The firm provides training and education services for medical professionals and healthcare industry. It was founded in 1997.

Bodycad enables orthopaedic surgeons to create a personalized restoration based on the anatomical specifications of their patient using the company's proprietary Personalized Restoration™ Software. Surgeons can quickly and efficiently step through the Bodycad PREP (Personalized Restoration Evaluation Process™) to scan their patients and create a specific design plan, approve the design, and perform the restoration. The company is committed to providing high-touch education, training and service, including access to Bodycad PREPTechs™ to help assure surgical success.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal. MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.

TC1 LLC, part of Abbott Laboratories, is a company headquartered in the United States that manufactures blood pressure apparatus.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Part of Roche Holding AG, Roche Diabetes Care GmbH is a German company located in Mannheim that develops medicines and medical equipment. It was founded in 2014. Michael Wöhler is currently the CEO of the firm.\nThe company says this about itself: Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines. Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualising relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments.

Part of GE Healthcare Technologies, Inc., GE Precision Healthcare LLC is an American company that retails healthcare products.

San Diego-based Vektor Medical, Inc. is the developer of the world’s first technology to rapidly map arrhythmias anywhere in the heart using only 12-lead ECG data. This data is analyzed using proprietary computational modeling to create actionable 2D and 3D maps of potential arrhythmia sources. The company’s smart, simple, and non-invasive cardiac arrhythmia mapping platform aims to improve first-pass ablation success, lower risks from invasive mapping and long fluoro exposure, and reduce procedure times, all of which are expected to reduce healthcare costs associated with ablation.

Surgical Theater, the market leader in virtual and augmented reality-based healthcare services, is the first to combine cutting-edge fighter jet flight simulation technology with a patient’s own anatomy scans, using medical imaging such as MRI, CT and DTI, to create a 360°-3D virtual reality reconstruction of the patient’s own anatomy and pathology. Precision VR revolutionizes patient engagement opportunities in the clinic while providing cutting-edge surgical planning and navigation capabilities in the operating room, as well as powerful tools for medical education and collaboration Surgical Theater 360°-3D XR platform is the only proven XR system in the market.